GlaxoSmithKline’s Nucala (mepolizumab) has gained a new FDA approval for the rare autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA). Nucala, an interleukin-5 (IL-5 ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with ...

While many presentation topics are not disclosed prior to the event, one anticipated highlight is from Anavex Life Sciences Corp (NASDAQ: AVXL), who is set to present Phase 2/3 data of blarcamesine ...

GSK announced that its monoclonal antibody, Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 ...

Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 million people in the country. This approval ...

Search Engine Land » PPC » Google Ads plans major AI Push in 2025, reshaping search marketing Chat with SearchBot Please note that your conversations will be recorded. Google Ads is preparing ...

Thousands of ads on Facebook and Instagram have promoted “fuel filters” using videos demonstrating how they can be easily modified into gun silencers—a process that, without federal approval ...

New York is the backdrop for famous holiday films such as “Miracle on 34th Street,” “Home Alone 2” and “Elf.” This year came a less felicitous kind when a video appeared of a woman ...